LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 228 filers reported holding SAGE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$978
-58.4%
500.0%0.00%
Q2 2023$2,351
+12.1%
500.0%0.00%
Q1 2023$2,098
+10.0%
500.0%0.00%
Q4 2022$1,907
-4.6%
500.0%0.00%
Q3 2022$2,0000.0%500.0%0.00%
Q2 2022$2,0000.0%500.0%0.00%
Q1 2022$2,0000.0%500.0%0.00%
Q4 2021$2,0000.0%500.0%0.00%
Q3 2021$2,000
-33.3%
500.0%0.00%
Q2 2021$3,000
-25.0%
500.0%0.00%
Q4 2020$4,000
+33.3%
500.0%0.00%
Q3 2020$3,000
+50.0%
500.0%0.00%
Q2 2020$2,000
+100.0%
500.0%0.00%
Q1 2020$1,000
-75.0%
500.0%0.00%
Q4 2019$4,000
-42.9%
500.0%0.00%
Q3 2019$7,000
-22.2%
500.0%0.00%
Q2 2019$9,000
+12.5%
500.0%0.00%
Q1 2019$8,000
+60.0%
500.0%0.00%
Q4 2018$5,000
-28.6%
500.0%0.00%
Q3 2018$7,000
-12.5%
500.0%0.00%
Q2 2018$8,0000.0%500.0%0.00%
Q1 2018$8,0000.0%500.0%0.00%
Q4 2017$8,000
+166.7%
500.0%0.00%
Q3 2017$3,000
-25.0%
500.0%0.00%
Q2 2017$4,000500.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Finepoint Capital LP 475,600$15,362,0005.31%
Integral Health Asset Management, LLC 412,257$13,316,0002.74%
Palo Alto Investors LP 851,409$27,501,0002.40%
Boxer Capital, LLC 1,094,000$35,336,0002.24%
DAFNA Capital Management LLC 180,306$5,824,0001.59%
Ikarian Capital, LLC 250,000$8,075,0001.47%
Bellevue Group AG 2,973,178$96,034,0001.36%
SECTOR GAMMA AS 118,476$3,827,0000.86%
Artal Group S.A. 450,000$14,535,0000.78%
Diametric Capital, LP 19,393$626,0000.46%
View complete list of SAGE THERAPEUTICS INC shareholders